{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T02:45:29Z","timestamp":1785033929691,"version":"3.55.0"},"reference-count":146,"publisher":"Bioscientifica","issue":"4","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>It is well known that sex steroids are involved in the growth of breast cancers, and the great majority of breast carcinomas express estrogen (ER), progesterone (PR), and androgen (AR) receptors. In particular, recent studies have demonstrated that estrogens and androgens are locally produced in breast carcinoma tissues, and total blockade of in situ estrogen production potentially leads to an improvement in prognosis of breast cancer patients. Therefore, it is important to obtain a better understanding of sex steroid-producing enzymes in breast carcinoma tissues. In this review, we summarize recent studies on the expression and regulation of enzymes related to intratumoral production of estrogens (aromatase, 17\u03b2-hydroxysteroid dehydrogenase type 1 (17\u03b2HSD1), and steroid sulfatase (STS) etc) and androgens (17\u03b2HSD5 and 5\u03b1-reductase) in human breast carcinoma tissues, and discuss the biological and\/or clinical significance of these enzymes. The cellular localization of aromatase in breast carcinoma tissues still remains controversial. Therefore, we examined localization of aromatase mRNA in breast carcinoma tissues by laser capture microdissection\/real time-polymerase chain reaction. Aromatase mRNA expression was detected in both carcinoma and intratumoral stromal cells, and the expression level of aromatase mRNA was higher in intratumoral stromal cells than in carcinoma cells in the cases examined. We also examined an association among the immunoreactivity of enzymes related to intratumoral estrogen production and ERs in breast carcinoma tissues, but no significant association was detected. Therefore, the enzymes responsible for the intratumoral production of estrogen may not always be the same among breast cancer patients, and not only aromatase but also other enzymes such as STS and 17\u03b2HSD1 may have important therapeutic potential as targets for endocrine therapy in breast cancer patients.<\/jats:p>","DOI":"10.1677\/erc.1.00834","type":"journal-article","created":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T14:06:49Z","timestamp":1133446009000},"page":"701-720","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":143,"title":["Sex steroid-producing enzymes in human breast cancer"],"prefix":"10.1530","volume":"12","author":[{"given":"Takashi","family":"Suzuki","sequence":"first","affiliation":[{"name":"Departments of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Miki","sequence":"additional","affiliation":[{"name":"Departments of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Departments of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Moriya","sequence":"additional","affiliation":[{"name":"Departments of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Ito","sequence":"additional","affiliation":[{"name":"1Obstetrics and Gynecology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Ohuchi","sequence":"additional","affiliation":[{"name":"2Surgical Oncology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[{"name":"Departments of Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"2026070909205089700_ADAMS-ETAL-1979","unstructured":"Adams\n              JB\n            \n          , Pewnim T, Chandra DP, Archibald L & Foo MS 1979 A correlation between estrogen sulfotransferase levels and estrogen receptor status in human primary breast carcinoma. Cancer Research395124\u20135126."},{"key":"2026070909205089700_ADJEI-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Adjei\n              AA\n            \n          , Thomae BA, Prondzinski JL, Eckloff BW, Wieben ED & Weinshilboum RM 2003 Human estrogen sulfotransferase (SULT1E1) pharmacogenomics: gene resequencing and functional genomics. British Journal of Pharmacology1391373\u20131382.","DOI":"10.1038\/sj.bjp.0705369"},{"key":"2026070909205089700_AKSOY-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Aksoy\n              IA\n            \n          , Wood TC & Weinshilboum R 1994 Human liver estrogen sulfotransferase: identification by cDNA cloning and expression. Biochemical and Biophysical Research Communications2001621\u20131629.","DOI":"10.1006\/bbrc.1994.1637"},{"key":"2026070909205089700_ANGUS-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Angus\n              WG\n            \n          , Larsen MC & Jefcoate CR 1999 Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status. Carcinogenesis20947\u2013955.","DOI":"10.1093\/carcin\/20.6.947"},{"key":"2026070909205089700_ARIGA-ETAL-2000","unstructured":"Ariga\n              N\n            \n          , Moriya T, Suzuki T, Kimura M, Ohuchi N, Satomi S & Sasano H 2000 17Beta-hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast. Anticancer Research201101\u20131108."},{"key":"2026070909205089700_ARUN-AND-GOSS-2004","doi-asserted-by":"crossref","unstructured":"Arun\n              B\n            \n           & Goss P 2004 The role of COX-2 inhibition in breast cancer treatment and prevention. Seminars in Oncology3122\u201329.","DOI":"10.1053\/j.seminoncol.2004.03.042"},{"key":"2026070909205089700_BAUM-2004","doi-asserted-by":"crossref","unstructured":"Baum\n              M\n            \n          \n          2004 Current status of aromatase inhibitors in the management of breast cancer and critique of the NCIC MA-17 trial. Cancer Control11217\u2013221.","DOI":"10.1177\/107327480401100402"},{"key":"2026070909205089700_BAUM-ETAL-2002","unstructured":"Baum\n              M\n            \n          , Budzar AU, Cuzick J, Forbes J, Houghton JH, Klijn JG & Sahmoud T and the ATAC Trialists\u2019 Group 2002 Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet3592131\u20132139."},{"key":"2026070909205089700_BAUM-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Baum\n              M\n            \n          , Buzdar A, Cuzick J, Forbes J, Houghton J, Howell A & Sahmoud T and the ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists\u2019 Group 2003 Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer981802\u20131810.","DOI":"10.3816\/CBC.2004.s.008"},{"key":"2026070909205089700_BEZWODA-ETAL-1987","doi-asserted-by":"crossref","unstructured":"Bezwoda\n              WR\n            \n          , Mansoor N & Dansey R 1987 Correlation of breast tumour aromatase activity and response to aromatase inhibition with aminoglutethimide. Oncology44345\u2013349.","DOI":"10.1016\/0022-4731(87)91520-2"},{"key":"2026070909205089700_BISTOLAS-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Bistolas\n              N\n            \n          , Wollenberger U, Jung C & Scheller FW 2005 Cytochrome P450 biosensors \u2014 a review. Biosensors and Bioelectronics202408\u20132423.","DOI":"10.1016\/j.bios.2004.11.023"},{"key":"2026070909205089700_BOLUFER-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Bolufer\n              P\n            \n          , Ricart E, Lluch A, Vazquez C, Rodriguez A, Ruiz A, Llopis F, Garcia-Conde J & Romero R 1992 Aromatase activity and estradiol in human breast cancer: its relationship to estradiol and epidermal growth factor receptors and to tumor-node-metastasis staging. Journal of Clinical Oncology10438\u2013446.","DOI":"10.1200\/JCO.1992.10.3.438"},{"key":"2026070909205089700_BRODIE-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Brodie\n              AM\n            \n          , Lu Q, Long BJ, Fulton A, Chen T, Macpherson N, DeJong PC, Blankenstein MA, Nortier JW, Slee PH, van de Ven J, van Gorp JM, Elbers JR, Schipper ME, Blijham GH & Thijssen JH 2001 Aromatase and COX-2 expression in human breast cancers. Journal of Steroid Biochemistry and Molecular Biology7941\u201347.","DOI":"10.1016\/S0960-0760(01)00131-5"},{"key":"2026070909205089700_BRUEGGEMEIER-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Brueggemeier\n              RW\n            \n          , Hackett JC & Diaz-Cruz ES 2005 Aromatase inhibitors in the treatment of breast cancer. Endocrine Reviews26331\u2013345.","DOI":"10.1210\/er.2004-0015"},{"key":"2026070909205089700_BULUN-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Bulun\n              SE\n            \n          , Price TM, Aitken J, Mahendroo MS & Simpson ER 1993 A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. Journal of Clinical Endocrinology and Metabolism771622\u20131628.","DOI":"10.1210\/jcem.77.6.8117355"},{"key":"2026070909205089700_CHETRITE-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Chetrite\n              G\n            \n          , Le Nestour E & Pasqualini JR 1998 Human estrogen sulfotransferase (hEST1) activities and its mRNA in various breast cancer cell lines. Effect of the progestin, promegestone (R-5020). Journal of Steroid Biochemistry and Molecular Biology66295\u2013302.","DOI":"10.1016\/S0960-0760(98)00063-6"},{"key":"2026070909205089700_CHETRITE-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Chetrite\n              GS\n            \n          , Cortes-Prieto J, Philippe JC, Wright F & Pasqualini JR 2000 Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues. Journal of Steroid Biochemistry and Molecular Biology7223\u201327.","DOI":"10.1016\/S0960-0760(00)00040-6"},{"key":"2026070909205089700_CLYNE-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Clyne\n              CD\n            \n          , Speed CJ, Zhou J & Simpson ER 2002 Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes. Journal of Biological Chemistry27720591\u201320597.","DOI":"10.1074\/jbc.M201117200"},{"key":"2026070909205089700_COOMBES-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Coombes\n              RC\n            \n          , Hall E, Gibson LJ, Paridaens R, Jassem J, Delozier T, Jones SE, Alvarez I, Bertelli G, Ortmann O, Coates AS, Bajetta E, Dodwell D, Coleman RE, Fallowfield LJ, Mickiewicz E, Andersen J, Lonning PE, Cocconi G, Stewart A, Stuart N, Snowdon CF, Carpentieri M, Massimini G & Bliss JM and the Intergroup Exemestane Study 2004 A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. New England Journal of Medicine3501081\u20131092.","DOI":"10.1056\/NEJMoa040331"},{"key":"2026070909205089700_DIAZ-CRUZ-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Diaz-Cruz\n              ES\n            \n          , Shapiro CL & Brueggemeier RW 2005 Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells. Journal of Clinical Endocrinology and Metabolism902563\u20132570.","DOI":"10.1210\/jc.2004-2029"},{"key":"2026070909205089700_DUFORT-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Dufort\n              I\n            \n          , Rheault P, Huang XF, Soucy P & Luu-The V 1999 Characteristics of a highly labile human type 5 17beta-hydroxysteroid dehydrogenase. Endocrinology140568\u2013574.","DOI":"10.1210\/endo.140.2.6531"},{"key":"2026070909205089700_ELLIS-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Ellis\n              MJ\n            \n          , Coop A, Singh B, Mauriac L, Llombert-Cussac A, Janicke F, Miller WR, Evans DB, Dugan M, Brady C, Quebe-Fehling E & Borgs M 2001 Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and\/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. Journal of Clinical Oncology193808\u20133816.","DOI":"10.1200\/JCO.2001.19.18.3808"},{"key":"2026070909205089700_EL-RAYES-ETAL-2003","unstructured":"El-Rayes\n              BF\n            \n          , Ali S, Heilbrun LK, Lababidi S, Bouwman D, Visscher D & Philip PA 2003 Cytochrome p450 and glutathione transferase expression in human breast cancer. Clinical Cancer Research9705\u2013709."},{"key":"2026070909205089700_ENEMAN-ETAL-2004","unstructured":"Eneman\n              JD\n            \n          , Wood ME & Muss HB 2004 Selecting adjuvant endocrine therapy for breast cancer. Oncology181733\u20131744, discussion 1744\u20131745, 1748, 1751\u20131754."},{"key":"2026070909205089700_ESTEBAN-ETAL-1992","unstructured":"Esteban\n              JM\n            \n          , Warsi Z, Haniu M, Hall P, Shively JE & Chen S 1992 Detection of intratumoral aromatase in breast carcinomas. An immunohistochemical study with clinicopathologic correlation. American Journal of Pathology140337\u2013343."},{"key":"2026070909205089700_EVANS-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Evans\n              TR\n            \n          , Rowlands MG, Law M & Coombes RC 1994 Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma. British Journal of Cancer69555\u2013561.","DOI":"10.1038\/bjc.1994.101"},{"key":"2026070909205089700_FALANY-AND-FALANY-1996","unstructured":"Falany\n              JL\n            \n           & Falany CN 1996 Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines. Cancer Research561551\u20131555."},{"key":"2026070909205089700_FALANY-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Falany\n              CN\n            \n          , Krasnykh V & Falany JL 1995 Bacterial expression and characterization of a cDNA for human liver estrogen sulfotransferase. Journal of Steroid Biochemistry and Molecular Biology52529\u2013539.","DOI":"10.1016\/0960-0760(95)00015-R"},{"key":"2026070909205089700_FALANY-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Falany\n              JL\n            \n          , Macrina N & Falany CN 2002 Regulation of MCF-7 breast cancer cell growth by beta-estradiol sulfation. Breast Cancer Research and Treatment74167\u2013176.","DOI":"10.1023\/A:1016147004188"},{"key":"2026070909205089700_FRASOR-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Frasor\n              J\n            \n          , Danes JM, Komm B, Chang KC, Lyttle CR & Katzenellenbogen BS 2003 Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology1444562\u20134574.","DOI":"10.1210\/en.2003-0567"},{"key":"2026070909205089700_GALANT-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Galant\n              C\n            \n          , Gala JL, Van Den Berge V, Berliere M, Haumont E & Horsmans Y 2001 Immunolocalisation of cytochrome P-450 3A enzymes in human breast carcinoma: relationship with tumour differentiation and steroid receptors. Pharmacology and Toxicology88142\u2013146.","DOI":"10.1034\/j.1600-0773.2001.d01-95.x"},{"key":"2026070909205089700_GEISSLER-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Geissler\n              WM\n            \n          , Davis DL, Wu L, Bradshaw KD, Patel S, Mendonca BB, Elliston KO, Wilson JD, Russell DW & Andersson S 1994 Male pseudohermaphroditism caused by mutations of testicular 17beta-hydroxysteroid dehydrogenase 3. Nature Genetics734\u201339.","DOI":"10.1038\/ng0594-34"},{"key":"2026070909205089700_GINGRAS-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Gingras\n              S\n            \n          , Moriggl R, Groner B & Simard J 1999 Induction of 3beta-hydroxysteroid dehydrogenase\/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13. Molecular Endocrinology1366\u201381.","DOI":"10.1210\/mend.13.1.0221"},{"key":"2026070909205089700_GINGRAS-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Gingras\n              S\n            \n          , Cote S & Simard J 2000 Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase\/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells. Molecular Endocrinology14229\u2013240.","DOI":"10.1210\/me.14.2.229"},{"key":"2026070909205089700_GOSS-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Goss\n              PE\n            \n          , Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ, Castiglione M, Tu D, Shepherd LE, Pritchard KI, Livingston RB, Davidson NE, Norton L, Perez EA, Abrams JS, Therasse P, Palmer MJ & Pater JL 2003 A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. New England Journal of Medicine3491793\u20131802.","DOI":"10.1056\/NEJMoa032312"},{"key":"2026070909205089700_GREEVE-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Greeve\n              MA\n            \n          , Allan RK, Harvey JM & Bentel JM 2004 Inhibition of MCF-7 breast cancer cell proliferation by 5alpha-dihydrotestosterone; a role for p21(Cip1\/Waf1). Journal of Molecular Endocrinology32793\u2013810.","DOI":"10.1677\/jme.0.0320793"},{"key":"2026070909205089700_GUNASEGARAM-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Gunasegaram\n              R\n            \n          , Peh KL, Loganath A & Ratnam SS 1998 Expression of 3beta-hydroxysteroid dehydrogenase-5,4-en isomerase activity by infiltrating ductal human breast carcinoma in vitro. Breast Cancer Research and Treatment50117\u2013123.","DOI":"10.1023\/A:1006009031839"},{"key":"2026070909205089700_GUNNARSSON-ETAL-2001","unstructured":"Gunnarsson\n              C\n            \n          , Olsson BM & Stal O and the Southeast Sweden Breast Cancer Group 2001 Abnormal expression of 17beta-hydroxysteroid dehydrogenases in breast cancer predicts late recurrence. Cancer Research618448\u20138451."},{"key":"2026070909205089700_GUNNARSSON-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Gunnarsson\n              C\n            \n          , Ahnstrom M, Kirschner K, Olsson B, Nordenskjold B, Rutqvist LE, Skoog L & Stal O 2003 Amplification of HSD17B1 and ERBB2 in primary breast cancer. Oncogene2234\u201340.","DOI":"10.1038\/sj.onc.1206078"},{"key":"2026070909205089700_HELLMOLD-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Hellmold\n              H\n            \n          , Rylander T, Magnusson M, Reihner E, Warner M & Gustafsson JA 1998 Characterization of cytochrome P450 enzymes in human breast tissue from reduction mammaplasties. Journal of Clinical Endocrinology and Metabolism83886\u2013895.","DOI":"10.1210\/jc.83.3.886"},{"key":"2026070909205089700_HOWELL-ETAL-2005","unstructured":"Howell\n              A\n            \n          , Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, Hoctin-Boes G, Houghton J, Locker GY & Tobias and the ATAC Trialists\u2019 Group 2005 Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years\u2019 adjuvant treatment for breast cancer. Lancet36560\u201362."},{"key":"2026070909205089700_HUANG-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Huang\n              Z\n            \n          , Fasco MJ, Figge HL, Keyomarsi K & Kaminsky LS 1996 Expression of cytochromes P450 in human breast tissue and tumors. Drug Metabolism and Disposition: the biological fate of chemicals24899\u2013905.","DOI":"10.1016\/S0090-9556(25)07451-3"},{"key":"2026070909205089700_ISCAN-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Iscan\n              M\n            \n          , Klaavuniemi T, Coban T, Kapucuoglu N, Pelkonen O & Raunio H 2001 The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue. Breast Cancer Research and Treatment7047\u201354.","DOI":"10.1023\/A:1012526406741"},{"key":"2026070909205089700_ISOLA-1993","unstructured":"Isola\n              JJ\n            \n          \n          1993 Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors. Journal of Pathology17031\u201335."},{"key":"2026070909205089700_JI-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Ji\n              Q\n            \n          , Aoyama C, Nien YD, Liu PI, Chen PK, Chang L, Stanczyk FZ & Stolz A 2004 Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling. Cancer Research647610\u20137617.","DOI":"10.1158\/0008-5472.CAN-04-1608"},{"key":"2026070909205089700_JIN-AND-PENNING-2001","doi-asserted-by":"crossref","unstructured":"Jin\n              Y\n            \n           & Penning TM 2001 Steroid 5alpha-reductases and 3alpha-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism. Best Practices and Research in Clinical Endocrinology and Metabolism1579\u201394.","DOI":"10.1053\/beem.2001.0120"},{"key":"2026070909205089700_DE-JONG-ETAL-2001","doi-asserted-by":"crossref","unstructured":"de Jong\n              PC\n            \n          , Blankenstein MA, van de Ven J, Nortier JW, Blijham GH & Thijssen JH 2001 Importance of local aromatase activity in hormone-dependent breast cancer: a review. Breast1091\u201399.","DOI":"10.1054\/brst.2000.0209"},{"key":"2026070909205089700_KAPUCUOGLU-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Kapucuoglu\n              N\n            \n          , Coban T, Raunio H, Pelkonen O, Edwards RJ, Boobis AR & Iscan M 2003 Expression of CYP3A4 in human breast tumour and non-tumour tissues. Cancer Letters20217\u201323.","DOI":"10.1016\/j.canlet.2003.08.015"},{"key":"2026070909205089700_KAURANIEMI-ETAL-2001","unstructured":"Kauraniemi\n              P\n            \n          , Barlund M, Monni O & Kallioniemi A 2001 New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. Cancer Research618235\u20138240."},{"key":"2026070909205089700_KINOSHITA-AND-CHEN-2003","unstructured":"Kinoshita\n              Y\n            \n           & Chen S 2003 Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha. Cancer Research633546\u20133555."},{"key":"2026070909205089700_KRISTENSEN-AND-BORRESEN-DALE-2000","unstructured":"Kristensen\n              VN\n            \n           & Borresen-Dale AL 2000 Molecular epidemiology of breast cancer: genetic variation in steroid hormone metabolism. Mutation Research462323\u2013333."},{"key":"2026070909205089700_LABRIE-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Labrie\n              F\n            \n          , Luu-The V, Labrie C, Belanger A, Simard J, Lin SX & Pelletier G 2003 Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocrine Reviews24152\u2013182.","DOI":"10.1210\/er.2001-0031"},{"key":"2026070909205089700_LAPOINTE-AND-LABRIE-2001","doi-asserted-by":"crossref","unstructured":"Lapointe\n              J\n            \n           & Labrie C 2001 Role of the cyclin-dependent kinase inhibitor p27(Kip1) in androgen-induced inhibition of CAMA-1 breast cancer cell proliferation. Endocrinology1424331\u20134338.","DOI":"10.1210\/endo.142.10.8417"},{"key":"2026070909205089700_LEERS-SUCHETA-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Leers-Sucheta\n              S\n            \n          , Morohashi K, Mason JI & Melner MH 1997 Synergistic activation of the human type II 3beta-hydroxysteroid dehydrogenase\/delta5-delta4 isomerase promoter by the transcription factor steroidogenic factor-1\/adrenal 4-binding protein and phorbol ester. Journal of Biological Chemistry2727960\u20137967.","DOI":"10.1074\/jbc.272.12.7960"},{"key":"2026070909205089700_LEWIS-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Lewis\n              MJ\n            \n          , Wiebe JP & Heathcote JG 2004 Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma. BMC Cancer427.","DOI":"10.1186\/1471-2407-4-27"},{"key":"2026070909205089700_LIEHR-2000","doi-asserted-by":"crossref","unstructured":"Liehr\n              JG\n            \n          \n          2000 Is estradiol a genotoxic mutagenic carcinogen? Endocrine Reviews2140\u201354.","DOI":"10.1210\/er.21.1.40"},{"key":"2026070909205089700_LIPTON-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Lipton\n              A\n            \n          , Santen RJ, Santner SJ, Harvey HA, Sanders SI & Matthews YL 1992 Prognostic value of breast cancer aromatase. Cancer701951\u20131955.","DOI":"10.1002\/1097-0142(19921001)70:7<1951::AID-CNCR2820700723>3.0.CO;2-#"},{"key":"2026070909205089700_LU-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Lu\n              Q\n            \n          , Nakmura J, Savinov A, Yue W, Weisz J, Dabbs DJ, Wolz G & Brodie A 1996 Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. Endocrinology1373061\u20133068.","DOI":"10.1210\/endo.137.7.8770932"},{"key":"2026070909205089700_LUU-THE-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Luu-The\n              V\n            \n          , Labrie C, Zhao HF, Couet J, Lachance Y, Simard J, Leblanc G, Cote J, Berube D, Gagne R & Labrie F 1989 Characterization of cDNAs for human estradiol 17beta-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5\u2032-termini in human placenta. Molecular Endocrinology31301\u20131309.","DOI":"10.1210\/mend-3-8-1301"},{"key":"2026070909205089700_LUU-THE-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Luu-The\n              V\n            \n          , Dufort I, Pelletier G & Labrie F 2001 Type 5 17beta-hydroxysteroid dehydrogenase: its role in the formation of androgens in women. Molecular and Cellular Endocrinology17177\u201382.","DOI":"10.1016\/S0303-7207(00)00425-1"},{"key":"2026070909205089700_MCFADYEN-ETAL-1999","doi-asserted-by":"crossref","unstructured":"McFadyen\n              MC\n            \n          , Breeman S, Payne S, Stirk C, Miller ID, Melvin WT & Murray GI 1999 Immunohistochemical localization of cytochrome P450 CYP1B1 in breast cancer with monoclonal antibodies specific for CYP1B1. Journal of Histochemistry and Cytochemistry471457\u20131464.","DOI":"10.1177\/002215549904701111"},{"key":"2026070909205089700_MACINDOE-AND-WOODS-1981","doi-asserted-by":"crossref","unstructured":"MacIndoe\n              JH\n            \n           & Woods GR 1981 Steroid-metabolizing enzymes in human breast cancer cells. II. 5Alpha-reductase, 3alpha-hydroxysteroid oxidoreductase, and 17beta-hydroxysteroid oxidoreductase. Endocrinology1081407\u20131413.","DOI":"10.1210\/endo-108-4-1407"},{"key":"2026070909205089700_MASUYAMA-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Masuyama\n              H\n            \n          , Hiramatsu Y, Kodama J & Kudo T 2003 Expression and potential roles of pregnane X receptor in endometrial cancer. Journal of Clinical Endocrinology and Metabolism884446\u20134454.","DOI":"10.1210\/jc.2003-030203"},{"key":"2026070909205089700_MASUYAMA-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Masuyama\n              H\n            \n          , Suwaki N, Tateishi Y, Nakatsukasa H, Segawa T & Hiramatsu Y 2005 The pregnane X receptor regulates gene expression in a ligand- and promoter-selective fashion. Molecular Endocrinology191170\u20131180.","DOI":"10.1210\/me.2004-0434"},{"key":"2026070909205089700_MIETTINEN-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Miettinen\n              M\n            \n          , Mustonen M, Poutanen M, Isomaa V, Wickman M, Soderqvist G, Vihko R & Vihko P 1999 17Beta-hydroxysteroid dehydrogenases in normal human mammary epithelial cells and breast tissue. Breast Cancer Research and Treatment57175\u2013182.","DOI":"10.1023\/A:1006217400137"},{"key":"2026070909205089700_MILEWICH-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Milewich\n              L\n            \n          , Shaw CE, Doody KM, Rainey WE, Mason JI & Carr BR 1991 3Beta-hydroxysteroid dehydrogenase activity in glandular and extraglandular human fetal tissues. Journal of Clinical Endocrinology and Metabolism731134\u20131140.","DOI":"10.1210\/jcem-73-5-1134"},{"key":"2026070909205089700_MILLER-1991","unstructured":"Miller\n              WR\n            \n          \n          1991 Aromatase activity in breast tissue. Journal of Steroid Biochemistry and Molecular Biology39783\u2013790."},{"key":"2026070909205089700_MILLER-AND-ONEILL-1987","unstructured":"Miller\n              WR\n            \n           & O\u2019Neill J 1987 The importance of local synthesis of estrogen within the breast. Steroids50537\u2013548."},{"key":"2026070909205089700_MILLER-ETAL-1990","doi-asserted-by":"crossref","unstructured":"Miller\n              WR\n            \n          , Anderson TJ & Jack WJ 1990 Relationship between tumour aromatase activity, tumour characteristics and response to therapy. Journal of Steroid Biochemistry and Molecular Biology371055\u20131059.","DOI":"10.1016\/0960-0760(90)90465-W"},{"key":"2026070909205089700_MILLER-ETAL-2003","unstructured":"Miller\n              WR\n            \n          , Anderson TJ, Evans DB, Krause A, Hampton G & Dixon JM 2003 An integrated view of aromatase and its inhibition. Journal of Steroid Biochemistry and Molecular Biology86413\u2013421."},{"key":"2026070909205089700_MIYOSHI-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Miyoshi\n              Y\n            \n          , Ando A, Shiba E, Taguchi T, Tamaki Y & Noguchi S 2001 Involvement of up-regulation of 17beta-hydroxysteroid dehydrogenase type 1 in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers. International Journal of Cancer94685\u2013689.","DOI":"10.1002\/ijc.1525"},{"key":"2026070909205089700_MIYOSHI-ETAL-2003","unstructured":"Miyoshi\n              Y\n            \n          , Ando A, Hasegawa S, Ishitobi M, Taguchi T, Tamaki Y & Noguchi S 2003 High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer. Clinical Cancer Research92288\u20132293."},{"key":"2026070909205089700_MODUGNO-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Modugno\n              F\n            \n          , Knoll C, Kanbour-Shakir A & Romkes M 2003 A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis. Breast Cancer Research and Treatment82191\u2013197.","DOI":"10.1023\/B:BREA.0000004376.21491.44"},{"key":"2026070909205089700_NEWMAN-ETAL-2000","unstructured":"Newman\n              SP\n            \n          , Purohit A, Ghilchik MW, Potter BV & Reed MJ 2000 Regulation of steroid sulphatase expression and activity in breast cancer. Journal of Steroid Biochemistry and Molecular Biology75259\u2013264."},{"key":"2026070909205089700_NUSSBAUMER-AND-BILLICH-2004","doi-asserted-by":"crossref","unstructured":"Nussbaumer\n              P\n            \n           & Billich A 2004 Steroid sulfatase inhibitors. Medical Research Reviews24529\u2013576.","DOI":"10.1002\/chin.200437257"},{"key":"2026070909205089700_ORTMANN-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Ortmann\n              J\n            \n          , Prifti S, Bohlmann MK, Rehberger-Schneider S, Strowitzki T & Rabe T 2002 Testosterone and 5alpha-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines. Gynecology and Endocrinology16113\u2013120.","DOI":"10.1080\/gye.16.2.113.120"},{"key":"2026070909205089700_OSBORNE-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Osborne\n              CK\n            \n          , Bardou V, Hopp TA, Chamness GC, Hilsenbeck SG, Fuqua SA, Wong J, Allred DC, Clark GM & Schiff R 2003 Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2\/neu in tamoxifen resistance in breast cancer. Journal of the National Cancer Institute95353\u2013361.","DOI":"10.1093\/jnci\/95.5.353"},{"key":"2026070909205089700_OSBORNE-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Osborne\n              CK\n            \n          , Shou J, Massarweh S & Schiff R 2005 Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clinical Cancer Research11865s\u2013870s.","DOI":"10.1158\/1078-0432.865s.11.2"},{"key":"2026070909205089700_OYAMA-ETAL-2005","unstructured":"Oyama\n              T\n            \n          , Morita M, Isse T, Kagawa N, Nakata S, So T, Mizukami M, Ichiki Y, Ono K, Sugaya M, Uramoto H, Yoshimatsu T, Hanagiri T, Sugio K, Kawamoto T & Yasumoto K 2005 Immunohistochemical evaluation of cytochrome P450 (CYP) and p53 in breast cancer. Frontiers in Bioscience101156\u20131161."},{"key":"2026070909205089700_PARKER-AND-SCHIMMER-1997","doi-asserted-by":"crossref","unstructured":"Parker\n              KL\n            \n           & Schimmer BP 1997 Steroidogenic factor 1: a key determinant of endocrine development and function. Endocrine Reviews18361\u2013377.","DOI":"10.1210\/edrv.18.3.0301"},{"key":"2026070909205089700_PASQUALINI-2003","doi-asserted-by":"crossref","unstructured":"Pasqualini\n              JR\n            \n          \n          2003 Differential effects of progestins on breast tissue enzymes. Maturitas46S45\u2013S54.","DOI":"10.1016\/j.maturitas.2003.09.018"},{"key":"2026070909205089700_PASQUALINI-2004","doi-asserted-by":"crossref","unstructured":"Pasqualini\n              JR\n            \n          \n          2004 The selective estrogen enzyme modulators in breast cancer: a review. Biochimica et Biophysica Acta1654123\u2013143.","DOI":"10.1016\/j.bbcan.2004.03.001"},{"key":"2026070909205089700_PASQUALINI-AND-CHETRITE-2005","unstructured":"Pasqualini\n              JR\n            \n           & Chetrite GS 2005 Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. Journal of Steroid Biochemistry and Molecular Biology93221\u2013236."},{"key":"2026070909205089700_PASQUALINI-ETAL-1994","unstructured":"Pasqualini\n              JR\n            \n          , Maloche C, Maroni M & Chetrite G 1994 Effect of the progestagen promegestone (R-5020) on mRNA of the oestrone sulphatase in the MCF-7 human mammary cancer cells. Anticancer Research141589\u20131593."},{"key":"2026070909205089700_PASQUALINI-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Pasqualini\n              JR\n            \n          , Chetrite G, Blacker C, Feinstein MC, Delalonde L, Talbi M & Maloche C 1996 Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. Journal of Clinical Endocrinology and Metabolism811460\u20131464.","DOI":"10.1210\/jcem.81.4.8636351"},{"key":"2026070909205089700_PELLETIER-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Pelletier\n              G\n            \n          , Luu-The V, Tetu B & Labrie F 1999 Immunocytochemical localization of type 5 17beta-hydroxysteroid dehydrogenase in human reproductive tissues. Journal of Histochemistry and Cytochemistry47731\u2013738.","DOI":"10.1177\/002215549904700602"},{"key":"2026070909205089700_PELTOKETO-ETAL-1998","unstructured":"Peltoketo\n              H\n            \n          , Isomaa V, Maentausta O & Vihko R 1998 Complete amino acid sequence of human placental 17beta-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Letters23973\u201377."},{"key":"2026070909205089700_PENNING-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Penning\n              TM\n            \n          , Burczynski ME, Jez JM, Lin HK, Ma H, Moore M, Ratnam K & Palackal N 2001 Structure \u2014function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3). Molecular and Cellular Endocrinology171137\u2013149.","DOI":"10.1016\/S0303-7207(00)00426-3"},{"key":"2026070909205089700_POIRIER-2003","doi-asserted-by":"crossref","unstructured":"Poirier\n              D\n            \n          \n          2003 Inhibitors of 17beta-hydroxysteroid dehydrogenases. Current Medical Chemistry10453\u2013477.","DOI":"10.2174\/0929867033368222"},{"key":"2026070909205089700_POUTANEN-ETAL-1992A","doi-asserted-by":"crossref","unstructured":"Poutanen\n              M\n            \n          , Isomaa V, Lehto VP & Vihko R 1992a Immunohistochemical analysis of 17\u03b2-hydroxysteroid dehydrogenase in benign and malignant human breast tissue. International Journal of Cancer50386\u2013390.","DOI":"10.1002\/ijc.2910500310"},{"key":"2026070909205089700_POUTANEN-ETAL-1992B","unstructured":"Poutanen\n              M\n            \n          , Moncharmont B & Vihko R 1992b 17-Hydroxysteroid dehydrogenase gene expression in human breast cancer cells: regulation of expression by a progestin. Cancer Research52290\u2013294."},{"key":"2026070909205089700_PUROHIT-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Purohit\n              A\n            \n          , Ghilchik MW, Duncan L, Wang DY, Singh A, Walker MM & Reed MJ 1995 Aromatase activity and interleukin-6 production by normal and malignant breast tissues. Journal of Clinical Endocrinology and Metabolism803052\u20133058.","DOI":"10.1210\/jcem.80.10.7559896"},{"key":"2026070909205089700_PUROHIT-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Purohit\n              A\n            \n          , Newman SP & Reed MJ 2002 The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Research465\u201369.","DOI":"10.1186\/bcr425"},{"key":"2026070909205089700_QIAN-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Qian\n              Y\n            \n          , Deng C & Song WC 1998 Expression of estrogen sulfotransferase in MCF-7 cells by cDNA transfection suppresses the estrogen response: potential role of the enzyme in regulating estrogen-dependent growth of breast epithelial cells. Journal of Pharmacology and Experimental Therapeutics286555\u2013560.","DOI":"10.1016\/S0022-3565(24)37617-7"},{"key":"2026070909205089700_QIU-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Qiu\n              W\n            \n          , Campbell RL, Gangloff A, Dupuis P, Boivin RP, Tremblay MR, Poirier D & Lin SX 2002 A concerted, rational design of type 1 17beta-hydroxysteroid dehydrogenase inhibitors: estradiol-adenosine hybrids with high affinity. FASEB Journal161829\u20131831.","DOI":"10.1096\/fj.02-0026fje"},{"key":"2026070909205089700_RAUNIO-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Raunio\n              H\n            \n          , Hakkola J & Pelkonen O 2005 Regulation of CYP3A genes in the human respiratory tract. Chemico-biological Interactactions15153\u201362.","DOI":"10.1016\/j.cbi.2003.12.007"},{"key":"2026070909205089700_RECCHIONE-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Recchione\n              C\n            \n          , Venturelli E, Manzari A, Cavalleri A, Martinetti A & Secreto G 1995 Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues. Journal of Steroid Biochemistry and Molecular Biology52541\u2013546.","DOI":"10.1016\/0960-0760(95)00017-T"},{"key":"2026070909205089700_REED-AND-PUROHIT-2001","unstructured":"Reed\n              MJ\n            \n           & Purohit A 2001 Aromatase regulation and breast cancer. Clinical Endocrinology54563\u2013571."},{"key":"2026070909205089700_REED-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Reed\n              MJ\n            \n          , Rea D, Duncan LJ & Parker MG 1994 Regulation of estradiol 17beta-hydroxysteroid dehydrogenase expression and activity by retinoic acid in T47D breast cancer cells. Endocrinology1354\u20139.","DOI":"10.1210\/endo.135.1.8013376"},{"key":"2026070909205089700_REED-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Reed\n              MJ\n            \n          , Purohit A, Woo LW, Newman SP & Potter BV 2005 Steroid sulfatase: molecular biology, regulation, and inhibition. Endocrine Reviews26171\u2013202.","DOI":"10.1210\/er.2004-0003"},{"key":"2026070909205089700_RHEAUME-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Rheaume\n              E\n            \n          , Lachance Y, Zhao HF, Breton N, Dumont M, de Launoit Y, Trudel C, Luu-The V, Simard J & Labrie F 1991 Structure and expression of a new complementary DNA encoding the almost exclusive 3beta-hydroxysteroid dehydrogenase\/delta 5-delta 4-isomerase in human adrenals and gonads. Molecular Endocrinology51147\u20131157.","DOI":"10.1210\/mend-5-8-1147"},{"key":"2026070909205089700_ROBERTSON-AND-BLAMEY-2003","doi-asserted-by":"crossref","unstructured":"Robertson\n              JF\n            \n           & Blamey RW 2003 The use of gonadotrophin-releasing hormone (GnRH) agonists in early and advanced breast cancer in pre- and perimenopausal women. European Journal of Cancer39861\u2013869.","DOI":"10.1016\/S0959-8049(02)00810-9"},{"key":"2026070909205089700_RUSSELL-AND-WILSON-1994","doi-asserted-by":"crossref","unstructured":"Russell\n              DW\n            \n           & Wilson JD 1994 Steroid 5alpha-reductase: two genes\/two enzymes. Annual Review of Biochemistry6325\u201361.","DOI":"10.1146\/annurev.bi.63.070194.000325"},{"key":"2026070909205089700_SAEKI-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Saeki\n              T\n            \n          , Takashima S, Sasaki H, Hanai N & Salomon DS 1999 Localization of estrone sulfatase in human breast carcinomas. Breast Cancer6331\u2013337.","DOI":"10.1007\/BF02966449"},{"key":"2026070909205089700_SAKAMOTO-ETAL-2002","unstructured":"Sakamoto\n              H\n            \n          , Utsumi T, Honda S, Yoshimura N, Sasaki E & Harada N 2002 The intraclinological estrogen metabolism in breast cancer cell lines. Program of the 6th International Aromatase Conference, Kyoto, Japan, p 113 (Abstract P 6\u20132)."},{"key":"2026070909205089700_SANTEN-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Santen\n              RJ\n            \n          , Martel J, Hoagland M, Naftolin F, Roa L, Harada N, Hafer L, Zaino R & Santner SJ 1994 Stromal spindle cells contain aromatase in human breast tumors. Journal of Clinical Endocrinology and Metabolism79627\u2013632.","DOI":"10.1210\/jcem.79.2.8045987"},{"key":"2026070909205089700_SANTNER-ETAL-1984","doi-asserted-by":"crossref","unstructured":"Santner\n              SJ\n            \n          , Feil PD & Santen RJ 1984In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. Journal of Clinical Endocrinology and Metabolism5929\u201333.","DOI":"10.1210\/jcem-59-1-29"},{"key":"2026070909205089700_SASANO-AND-HARADA-1998","doi-asserted-by":"crossref","unstructured":"Sasano\n              H\n            \n           & Harada N 1998 Intratumoral aromatase in human breast, endometrial, and ovarian malignancies. Endocrine Reviews19593\u2013607.","DOI":"10.1210\/edrv.19.5.0342"},{"key":"2026070909205089700_SASANO-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Sasano\n              H\n            \n          , Nagura H, Harada N, Goukon Y & Kimura M 1994 Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Human Pathology5530\u2013533.","DOI":"10.1016\/0046-8177(94)90127-9"},{"key":"2026070909205089700_SASANO-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Sasano\n              H\n            \n          , Frost AR, Saitoh R, Harada N, Poutanen M, Vihko R, Bulun SE, Silverberg SG & Nagura H 1996 Aromatase and 17\u03b2-hydroxysteroid dehydrogenase type 1 in human breast carcinoma. Journal of Clinical Endocrinology and Metabolism814042\u20134046.","DOI":"10.1210\/jcem.81.11.8923858"},{"key":"2026070909205089700_SASANO-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Sasano\n              H\n            \n          , Edwards DP, Anderson TJ, Silverberg SG, Evans DB, Santen RJ, Ramage P, Simpson ER, Bhatnagar AS & Miller WR 2003 Validation of new aromatase monoclonal antibodies for immunohistochemistry: progress report. Journal of Steroid Biochemistry and Molecular Biology86239\u2013244.","DOI":"10.1016\/S0960-0760(03)00363-7"},{"key":"2026070909205089700_SEBASTIAN-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Sebastian\n              S\n            \n          , Takayama K, Shozu M & Bulun SE 2002 Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue. Molecular Endocrinology162243\u20132254.","DOI":"10.1210\/me.2002-0123"},{"key":"2026070909205089700_SHENTON-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Shenton\n              KC\n            \n          , Dowsett M, Lu Q, Brodie A, Sasano H, Sacks NP & Rowlands MG 1998 Comparison of biochemical aromatase activity with aromatase immunohistochemistry in human breast carcinomas. Breast Cancer Research and Treatment49S101\u2013S107; discussion S109\u2013S119.","DOI":"10.1023\/A:1006033813899"},{"key":"2026070909205089700_SILVA-ETAL-1989","unstructured":"Silva\n              MC\n            \n          , Rowlands MG, Dowsett M, Gusterson B, McKinna JA, Fryatt I & Coombes RC 1989 Intratumoral aromatase as a prognostic factor in human breast carcinoma. Cancer Research492588\u20132591."},{"key":"2026070909205089700_SIMARD-AND-GINGRAS-2001","unstructured":"Simard\n              J\n            \n           & Gingras S 2001 Crucial role of cytokines in sex steroid formation in normal and tumoral tissues. Molecular and Cellular Endocrinology17125\u201340."},{"key":"2026070909205089700_SIMPSON-AND-DAVIS-2001","doi-asserted-by":"crossref","unstructured":"Simpson\n              ER\n            \n           & Davis SR 2001 Minireview: aromatase and the regulation of estrogen biosynthesis \u2014 some new perspectives. Endocrinology1424589\u20134594.","DOI":"10.1210\/endo.142.11.8547"},{"key":"2026070909205089700_SINGH-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Singh\n              A\n            \n          , Purohit A, Ghilchik MW & Reed MJ 1999 The regulation of aromatase activity in breast fibroblasts: the role of interleukin-6 and prostaglandin E2. Endocrine-Related Cancer6139\u2013147.","DOI":"10.1677\/erc.0.0060139"},{"key":"2026070909205089700_SIRIANNI-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Sirianni\n              R\n            \n          , Seely JB, Attia G, Stocco DM, Carr BR, Pezzi V & Rainey WE 2002 Liver receptor homologue-1 is expressed in human steroidogenic tissues and activates transcription of genes encoding steroidogenic enzymes. Journal of Endocrinology174R13\u2013R17.","DOI":"10.1677\/joe.0.174r013"},{"key":"2026070909205089700_SOMBOONPORN-AND-DAVIS-2004","doi-asserted-by":"crossref","unstructured":"Somboonporn\n              W\n            \n           & Davis SR and the National Health and Medical Research Council 2004 Testosterone effects on the breast: implications for testosterone therapy for women. Endocrine Reviews25374\u2013388.","DOI":"10.1210\/er.2003-0016"},{"key":"2026070909205089700_SONNE-HANSEN-AND-LYKKESFELDT-2005","doi-asserted-by":"crossref","unstructured":"Sonne-Hansen\n              K\n            \n           & Lykkesfeldt AE 2005 Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line. Journal of Steroid Biochemistry and Molecular Biology9325\u201334.","DOI":"10.1016\/j.jsbmb.2004.11.005"},{"key":"2026070909205089700_SPEIRS-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Speirs\n              V\n            \n          , Green AR, Walton DS, Kerin MJ, Fox JN, Carleton PJ, Desai SB & Atkin SL 1998 Short-term primary culture of epithelial cells derived from human breast tumours. British Journal of Cancer781421\u20131429.","DOI":"10.1038\/bjc.1998.702"},{"key":"2026070909205089700_SPINK-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Spink\n              BC\n            \n          , Katz BH, Hussain MM, Pang S, Connor SP, Aldous KM, Gierthy JF & Spink DC 2000 SULT1A1 catalyzes 2-methoxyestradiol sulfonation in MCF-7 breast cancer cells. Carcinogenesis211947\u20131957.","DOI":"10.1093\/carcin\/21.11.1947"},{"key":"2026070909205089700_SURMACZ-AND-BARTUCCI-2004","unstructured":"Surmacz\n              E\n            \n           & Bartucci M 2004 Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer. Journal of Experimental Clinical Cancer Research23385\u2013394."},{"key":"2026070909205089700_SUZUKI-ETAL-2000A","doi-asserted-by":"crossref","unstructured":"Suzuki\n              T\n            \n          , Moriya T, Ariga N, Kaneko C, Kanazawa M & Sasano H 2000a 17Beta-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters. British Journal of Cancer82518\u2013523.","DOI":"10.1054\/bjoc.1999.0956"},{"key":"2026070909205089700_SUZUKI-ETAL-2000B","doi-asserted-by":"crossref","unstructured":"Suzuki\n              T\n            \n          , Sasano H, Andersson S & Mason JI 2000b 3Beta-hydroxysteroid dehydrogenase\/delta5\u2013 &gt; 4-isomerase activity associated with the human 17beta-hydroxysteroid dehydrogenase type 2 isoform. Journal of Clinical Endocrinology and Metabolism853669\u20133672.","DOI":"10.1210\/jc.85.10.3669"},{"key":"2026070909205089700_SUZUKI-ETAL-2001A","doi-asserted-by":"crossref","unstructured":"Suzuki\n              T\n            \n          , Darnel AD, Akahira JI, Ariga N, Ogawa S, Kaneko C, Takeyama J, Moriya T & Sasano H 2001a 5Alpha-reductases in human breast carcinoma: possible modulator of in situ androgenic actions. Journal of Clinical Endocrinology and Metabolism862250\u20132257.","DOI":"10.1210\/jcem.86.5.7444"},{"key":"2026070909205089700_SUZUKI-ETAL-2001B","doi-asserted-by":"crossref","unstructured":"Suzuki\n              T\n            \n          , Moriya T, Sugawara A, Ariga N, Takabayashi H & Sasano H 2001b Retinoid receptors in human breast carcinoma: possible modulators of in situ estrogen metabolism. Breast Cancer Research and Treatment6531\u201340.","DOI":"10.1023\/A:1006433929792"},{"key":"2026070909205089700_SUZUKI-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Suzuki\n              T\n            \n          , Murry BA, Darnel AD & Sasano H 2002 Progesterone metabolism in human leukemic monoblast U937 cells. Endocrine Journal49539\u2013546.","DOI":"10.1507\/endocrj.49.539"},{"key":"2026070909205089700_SUZUKI-ETAL-2003","unstructured":"Suzuki\n              T\n            \n          , Nakata T, Miki Y, Kaneko C, Moriya T, Ishida T, Akinaga S, Hirakawa H, Kimura M & Sasano H 2003 Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma. Cancer Research632762\u20132770."},{"key":"2026070909205089700_SUZUKI-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Suzuki\n              T\n            \n          , Miki Y, Moriya T, Shimada N, Ishida T, Hirakawa H, Ohuchi N & Sasano H 2004 Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor. Cancer Research644670\u20134676.","DOI":"10.1158\/0008-5472.CAN-04-0250"},{"key":"2026070909205089700_TREMBLAY-AND-BEAUDOIN-1993","doi-asserted-by":"crossref","unstructured":"Tremblay\n              Y\n            \n           & Beaudoin C 1993 Regulation of 3beta-hydroxysteroid dehydrogenase and 17beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels by cyclic adenosine 3\u2032, 5\u2032-monophosphate and phorbol myristate acetate in human choriocarcinoma cells. Molecular Endocrinology7355\u2013364.","DOI":"10.1210\/mend.7.3.8387158"},{"key":"2026070909205089700_TSENG-ETAL-1983","doi-asserted-by":"crossref","unstructured":"Tseng\n              L\n            \n          , Mazella J, Lee LY & Stone ML 1983 Estrogen sulfatase and estrogen sulfotransferase in human primary mammary carcinoma. Journal of Steroid Biochemistry41413\u20131417.","DOI":"10.1016\/0022-4731(83)91116-0"},{"key":"2026070909205089700_TSUCHIYA-ETAL-2004","unstructured":"Tsuchiya\n              Y\n            \n          , Nakajima M, Kyo S, Kanaya T, Inoue M & Yokoi T 2004 Human CYP1B1 is regulated by estradiol via estrogen receptor. Cancer Research643119\u20133125."},{"key":"2026070909205089700_UTSUMI-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Utsumi\n              T\n            \n          , Harada N, Maruta M & Takagi Y 1996 Presence of alternatively spliced transcripts of aromatase gene in human breast cancer. Journal of Clinical Endocrinology and Metabolism812344\u20132349.","DOI":"10.1210\/jcem.81.6.8964875"},{"key":"2026070909205089700_UTSUMI-ETAL-1999","unstructured":"Utsumi\n              T\n            \n          , Yoshimura N, Takeuchi S, Ando J, Maruta M, Maeda K & Harada N 1999 Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer. Cancer Research59377\u2013381."},{"key":"2026070909205089700_VIHKO-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Vihko\n              P\n            \n          , Herrala A, Harkonen P, Isomaa V, Kaija H, Kurkela R, Li Y, Patrikainen L, Pulkka A, Soronen P & Torn S 2005 Enzymes as modulators in malignant transformation. Journal of Steroid Biochemistry and Molecular Biology93277\u2013283.","DOI":"10.1016\/j.jsbmb.2005.01.002"},{"key":"2026070909205089700_WIEBE-ETAL-2000","unstructured":"Wiebe\n              JP\n            \n          , Muzia D, Hu J, Szwajcer D, Hill SA & Seachrist JL 2000 The 4-pregnene and 5alpha-pregnane progesterone metabolites formed in nontumorous and tumorous breast tissue have opposite effects on breast cell proliferation and adhesion. Cancer Research60936\u2013943."},{"key":"2026070909205089700_WIEBE-ETAL-2005","unstructured":"Wiebe\n              JP\n            \n          , Lewis MJ, Cialacu V, Pawlak KJ & Zhang G 2005 The role of progesterone metabolites in breast cancer: potential for new diagnostics and therapeutics. Journal of Steroid Biochemistry and Molecular Biology93201\u2013208."},{"key":"2026070909205089700_WU-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Wu\n              L\n            \n          , Einstein M, Geissler WM, Chan HK, Ellison KO & Andersson S 1993 Expression cloning and characterization of human 17\u03b2-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20\u03b1-hydroxysteroid dehydrogenase activity. Journal of Biological Chemistry16812964\u201312969.","DOI":"10.1016\/S0021-9258(18)31480-7"},{"key":"2026070909205089700_YAMAGUCHI-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Yamaguchi\n              Y\n            \n          , Takei H, Suemasu K, Kobayashi Y, Kurosumi M, Harada N & Hayashi S 2005 Tumor\u2013stromal interaction through the estrogen-signaling pathway in human breast cancer. Cancer Research654653\u20134662.","DOI":"10.1158\/0008-5472.CAN-04-3236"},{"key":"2026070909205089700_YAMAMOTO-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Yamamoto\n              Y\n            \n          , Yamashita J, Toi M, Muta M, Nagai S, Hanai N, Furuya A, Osawa Y, Saji S & Ogawa M 2003 Immunohistochemical analysis of estrone sulfatase and aromatase in human breast cancer tissues. Oncology Reports10791\u2013796.","DOI":"10.3892\/or.10.4.791"},{"key":"2026070909205089700_YANG-ETAL-1998","unstructured":"Yang\n              C\n            \n          , Zhou D & Chen S 1998 Modulation of aromatase expression in the breast tissue by ERR alpha-1 orphan receptor. Cancer Research585695\u20135700."},{"key":"2026070909205089700_YOSHIMURA-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Yoshimura\n              N\n            \n          , Harada N, Bukholm I, Karesen R, Borresen-Dale AL & Kristensen VN 2004 Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer. Breast Cancer Research6R46\u2013R55.","DOI":"10.1186\/bcr746"},{"key":"2026070909205089700_ZHAO-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Zhao\n              Y\n            \n          , Agarwal VR, Mendelson CR & Simpson ER 1996 Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology1375739\u20135742.","DOI":"10.1210\/endo.137.12.8940410"},{"key":"2026070909205089700_ZHOU-ETAL-2001","unstructured":"Zhou\n              J\n            \n          , Gurates B, Yang S, Sebastian S & Bulun SE 2001 Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial\u2013stromal interaction in breast tumors mediated by CCAAT\/enhancer binding protein beta. Cancer Research612328\u20132334."},{"key":"2026070909205089700_ZHOU-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Zhou\n              J\n            \n          , Suzuki T, Kovacic A, Saito R, Miki Y, Ishida T, Moriya T, Simpson ER, Sasano H & Clyne CD 2005 Interactions between prostaglandin E2, liver receptor homologue-1, and aromatase in breast cancer. Cancer Research65657\u2013663.","DOI":"10.1158\/0008-5472.657.65.2"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/12\/4\/0120701.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/12\/4\/701\/192548\/0120701.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/12\/4\/701\/192548\/0120701.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:21:08Z","timestamp":1783603268000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/12\/4\/701\/34546\/Sex-steroid-producing-enzymes-in-human-breast"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,1]]},"references-count":146,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12,1]]}},"URL":"https:\/\/doi.org\/10.1677\/erc.1.00834","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12,1]]}}}